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Traumatic brain injury (TBI) is a sudden event and the leading cause of death and disability among young people. Up to 95% of patients with severe TBI die,1 and 20% of the survivors experience a low quality of life.
2 
Due to the neurological impairment, patients are incapable 
of giving informed consent and discussing therapeutic 
options. Clinicians involved in the care of TBI deal with 
many ethical challenges3,4 such as determining appropriate 
treatment strategies for the patient during the vulnerable 
period in the intensive care unit (ICU), which might result 
in an unwanted futile outcome. Futile care is not defined by 
universally recognized, objective guidelines, but rather by 
the values of the patient, his or her family, and health care 
providers.5,6
Cultures, religions, and legislation7–9 influence end-of-
life (EOL) processes and the balance between ethical prin-
ciples. No standards exist for decision making on treatment 
for comatose patients, especially concerning life-saving 
KEY POINTS
• Question: How is the outcome and the decision-making process at the end of life of patients 
with traumatic brain injury in a Swiss academic hospital?
• Findings: The frequency of patients in vegetative state 6 months after injury is negligible 
(0.6%), and nonsudden deaths after conscious end of life are frequent (96%), after a stan-
dardized process based on interdisciplinary prognostication and involvement of surrogate 
decision makers.
• Meaning: The high prevalence of decisions to limit life-sustaining therapies to respect the 
documented or assumed will of patients might have led to an earlier death among patients 
who are potentially in vegetative state.
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to analyze outcomes and the decision-making process at the end of life (EOL) in patients with 
traumatic brain injury (TBI) in a Swiss academic tertiary care hospital.
METHODS: Consecutive admissions to the surgical intensive care unit (ICU) with stays of at 
least 48 hours between January 1, 2012 and June 30, 2015 in patients with moderate to 
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treatments.10–12 In Europe and the United States, the pre-
vailing ethical principles are respect for the patient’s will 
and his or her autonomy.13 In contrast, a more paternalistic 
approach is preferred by doctors and families in China.14
In Switzerland, the decision process is particular in 2 
ways. First, the community delegates wide competence to 
the treating physicians in determining whether the patient’s 
probable outcome is undesirable (ie, futile). For example, 
Swiss guidelines concerning life-sustaining treatments after 
resuscitation of adults15 differ from other countries.2 In cases 
of expected persistent high level of dependence, a limitation 
of life-prolonging therapies may be indicated if a life with 
severe disability would be contrary to the patient’s will. 
Second, the law relating to the protection of adults16 urges 
the treating physician to comply with the patient’s pre-
sumed will. The law further prescribes that a surrogate deci-
sion maker (SDM) needs to be appointed, normally a family 
member. Discussion with the SDM will determine further 
therapeutic decisions, based on what he or she believes that 
patient’s will would be. Accordingly, for patients unable to 
communicate, such as TBI patients, the SDM—and not the 
physician—decides on behalf of the patient.
Considering the intensity of the decision-making process 
for patients with TBI, the recent increased use of limitation 
of life-prolonging therapies in this specific population,17 
and the particularities of Swiss culture concerning the con-
cept of futility and SDM, this study analyzes outcome and 
the EOL process of patients with moderate and severe TBI 
in a Swiss university hospital.
METHODS
This retrospective, single-center study was conducted 
in the surgical ICU of the University Hospital of Zurich, 
Switzerland, a tertiary care hospital, in accordance with 
Good Clinical Practice guidelines, the provisions of the 
Declaration of Helsinki, and the national legal and regula-
tory requirements. The Institutional Ethics Committee of 
Zurich (KEK-ZH-Nr. 2016-00332) approved this project and 
waived the need for informed consent of the participants or 
their legal representatives (data were entered in the data-
base anonymously).
Inclusion Criteria
All adults (>15 years of age) with moderate to severe TBI 
(defined by a Glasgow Coma Scale [GCS] <13 before seda-
tion and intubation) admitted to the ICU between January 
1, 2012 and June 30, 2015 who died within 6 months after 
trauma were included. Similar to previous publications 
on this topic,18,19 we decided to include both moderate and 
severe TBI patients, to have a larger cohort of patients with-
out further extending the study period, to limit possible 
confounding factors in patient management.
Patients discharged from the ICU within 48 hours were 
excluded to prevent analyses of patients with initially over-
estimated severity20 and no need of intensive treatment (eg, 
due to the influence of alcohol at the time of trauma, whose 
prevalence is high in our population21) and to exclude 
early sudden fatalities occurring before a meeting with the 
SDM was held. At our ICU, decisions to limit life-prolong-
ing therapies are rarely taken within the first 48 hours, as 
recommended also for patients with intracranial hemor-
rhage.22 A meeting between medical staff and relatives is 
set up within the first 48 hours from trauma to discuss the 
prognosis and the patient’s will and to decide on a goal of 
care. This is based on the documented and assumed will 
of the patient and interdisciplinary prognostication, made 
by ICU doctors and nurses, neurologists, neurosurgeons, 
trauma surgeons, and ethics experts.
Data Collection
Subjects were retrospectively identified within the hospital’s 
electronic database (KISIMTM, Cistec Zurich, Switzerland), 
and data were retrieved if the subject was diagnosed with 
TBI (ICD Code S00-S09). Medical charts were reviewed, and 
TBI severity was classified according to the first GCS before 
sedation and intubation. A GCS of 12–8 defines a moderate 
and a GCS <8 a severe TBI.
Long-term functional outcomes were assessed by 2 
senior intensivists with experience in care of patients with 
TBI (S.K., U.E.). The Glasgow Outcome Scale (GOS) 6 
months after trauma was assessed with a structured ques-
tionnaire. Age, sex, length of stay in the ICU, duration of 
mechanical ventilation expressed in days, place of death, 
and the modality of EOL decision were recorded. The EOL 
decision was categorized into:
 1. Withholding of therapy: new or existing life-support 
therapy was not started or intensified (eg, cardiopul-
monary resuscitation, intubation, and mechanical 
ventilation);
 2. Withdrawal of therapy: active decision to stop or 
remove a life-sustaining treatment (eg, mechanical 
ventilation, high inspiratory fraction of oxygen, infu-
sion of catecholamines);
 3. Alleviation of pain and symptoms of agony: admin-
istration of sedatives (propofol or midazolam) and/
or opiates at the time of death.
Other data collected were:
• Time of the EOL decision (number of days after 
trauma);
• Time to death (number of days after trauma);
• Time elapsed from EOL decision and patient’s death 
(number of days);
• Presence of written advance directives (ADs) and/or 
information that patient discussed EOL issues with 
relatives before the trauma occurred;
• Initiator and people involved in EOL decisions (doc-
tors, nurses, SDMs, legal guardians);
• Prognostic scores: Injury Severity Score, and its head-
specific Abbreviated Injury Scale,  severity of systemic 
derangements during the first 24 hours in the ICU, as 
measured by the Simplified Acute Physiologic Score 
II, and the International Mission for Prognosis and 
Analysis of Clinical Trials (IMPACT) score for predic-
tion of mortality and unfavorable outcomes 6 months 
after TBI. The IMPACT score is based on age, clinical 
findings (GCS motor component, pupillary reactiv-
ity), computed tomographic characteristics, secondary 
insults (hypoxemia, hypotension), and laboratory val-
ues on admission (glucose, hemoglobin).
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EOL Process at Our Institution
At our ICU, a meeting with the SDM is organized within 
48 hours after ICU admission to explore plausible patient’s 
will and attitude to life and the family’s expectations. 
Reevaluations are repeated and SDMs are regularly informed. 
If a conflict arises between medical staff, family, and SDMs, an 
ethics expert is involved. As suggested by Geurts et al,23 these 
meetings are led by the attending physician, who informs the 
others on disease, treatment options, and prognosis with and 
without treatment. A brief report concerning the content of 
these meetings is included in the electronic medical records.
In cases of patients with locked-in syndrome, as long 
as the possibility to communicate with the patient is main-
tained—even if merely limited to movements of the eyes—
the patient should be involved in the decision process about 
goals of care. The SDM may confirm that the decision taken 
respects the patient’s will. Due to the peculiarity of this dis-
ease pattern, the expertise of an ethics expert could help to 
manage the case.
Statistical Analysis
Normal distribution of data was analyzed by D’Agostino-
Pearson omnibus normality test. For descriptive statistics, cat-
egorical variables were expressed as absolute numbers with 
percentages, normally distributed quantitative variables as 
means ± standard deviation, and nonnormally distributed 
variables as medians with interquartile ranges. For nonnormal 
distributed data, the calculation of confidence intervals (CIs) 
was based on the binomial distribution; for proportion, we 
used the Wilson-Brown method. Statistical analysis was per-
formed with Prism 6.00 (GraphPad Software, San Diego, CA).
Due to the retrospective nature of the study, the number 
of patients available was given. A sample size of 48 from 
a population of 10,000 produced a 2-sided 95% CI with a 
precision of 0.1197, when the actual proportion is near 
0.2500. Precision computation was performed with PASS 15 
(Kaysville, UT).
RESULTS
During the study period, 994 patients with TBI were consecu-
tively admitted to the ICU (Figure 1). Of these, 182 had an ini-
tial GCS <13 and length of stay in the ICU of >48 hours. Eight 
individuals were excluded because of a missing 6-month 
GOS. For the remaining 174 individuals, the GOS distribu-
tion was analyzed (Figure  2): 43.1% (36.0%–50.5%; n = 75) 
had favorable outcomes (GOS 4 or 5), 28.7% (22.5%–35.9%; 
n = 50) showed severe disability (GOS 3), 0.6% (0%–3.2%; 
n = 1) remained in a vegetative state (GOS 2), and 27.6% 
(21.5%–34.7%; n = 48) succumbed to their injuries (GOS 1). 
No cases of locked-in syndrome were recorded. Among the 
GOS 1 individuals, 45 patients had a complete dataset and 
fulfilled the inclusion criteria of the study.
Ninety-six percent of these patients (85.2%–99.2%) 
(N = 43) died in the hospital, and 4% (0.8%–14.8%) died in 
a rehabilitation clinic. Demographic data and prognostic 
scores are shown in Table 1.
Decision-Making Process
In the GOS 1 population (N = 45), an EOL decision was 
taken in 95.6% (85.2%–99.2%) (n = 43) of the cases (Table 2).
Written ADs were available for 14% (6.6%–27.3%) of 
patients, and an EOL conversation had been conducted 
with relatives before trauma in 34.9% (22.4%–49.8%) of 
the cases (in 5 of these cases, written ADs were available). 
The SDM was involved in the EOL process in all cases 
(96.3%, 100%). In 98% (87.9%–99.9%) of cases, a next of kin 
was the SDM. A legal guardian was appointed by Swiss 
authorities for 1 elderly patient without relatives (2.3%, 95% 
CI, 87.9%–99.9%).
Figure 1. Description of the study population. EOL indicates end-
of-life; GCS, Glasgow Coma Scale; GOS, Glasgow Outcome Scale; 
LOS-ICU, length of stay in the intensive care unit; TBI, traumatic 
brain injury.
Figure 2. Six-month Glasgow Outcome Scale distribution. N = 174 
patients. Glasgow Outcome Scale 1: death; Glasgow Outcome Scale 
2: vegetative state; Glasgow Outcome Scale 3: severe disability; 
Glasgow Outcome Scale 4: moderate disability; Glasgow Outcome 
Scale 5: good recovery.
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The EOL decision was initiated by doctors in 85.7% 
(72.2%–93.3%) of the cases. Doctors, nurses, and relatives 
were involved in the process (Table 2). In only 1 case did a 
conflict arise between family and physicians, and ethics and 
law experts were involved to solve it. No decision occurred 
without the presence of a SDM.
New goals of care after an EOL decision and discussion 
of palliative care modalities with the SDM are provided in 
Table 3.
DISCUSSION
In patients with moderate or severe TBI, we observed a 
negligible rate of 0.6% (0%–3.2%) of vegetative state at 
6 months after injury. This may be due to the high rate 
of deaths after conscious EOL decisions (95.6%, 95% CI, 
85.2%–99.2%) after interdisciplinary prognostication and 
involvement of the SDM to respect the documented or 
assumed patient’s will.
Outcome Futility
The rate of unfavorable outcomes (GOS 1–3) 6 months after TBI 
in our population was comparable to that found in the database24 
used to create the prognostic model IMPACT. Interestingly, we 
observed a negligible rate of vegetative state (GOS 2; 0.6%, 95% 
CI, 0%–3.2%), lower than that in cohorts from earlier reports. 
For example, the rate of vegetative state was higher in the 
Eurotherm trial25 (8% in the hypothermia group and 17% in the 
normothermia group) and in the DEcompressive CRAniectomy 
(DECRA) trial26 (12% in the decompressive craniectomy group 
and 2% in the control group).
Turgeon et al27 reported deaths after limitation of life-
sustaining therapies in 45%–87% of patients with TBI. In 
our population, this rate was higher, which might have led 
to an earlier death among patients who might potentially 
have become vegetative state cases.
The decision to limit life-sustaining therapies was based on 
the assumption that these would result in an unwanted out-
come, in not respecting the patient’s will, or in a futile outcome 
considered inappropriate by physicians.28 Futility as a concept 
is neither objective nor universally recognized. However, for 
our purposes, quantitative futility means that a proposed ther-
apy is unlikely to achieve the desired effect. On the other hand, 
qualitative futility means that a therapeutic action, even if suc-
cessful, will result in a nondesired outcome29: futility is goal 
specific and based on a subjective evaluation of whether the 
goal of the intervention is futile. In our study, as assessed by 
ADs and the patients’ assumed will, most individuals perceive 
persistent vegetative state and severe disability as undesirable 
and, thus, as futile outcomes, resulting in redirection of ther-
apy and the patient’s death, because the legal framework bases 
therapies on the patient’s will. Consequently, patients who 
would otherwise have survived, although potentially remain-
ing in vegetative state, passed away. This could explain why 
we observed a higher proportion of GOS1 cases than predicted 
by prognostic scores but a lower proportion of GOS2 cases.
The EOL Decision Process
Compared to other articles on EOL decisions after TBI,30,31 
our ICU is a late decision center: EOL decisions were taken 
on average 7 days after TBI, similar to the timing reported in 
a recent article referring to patients with intracranial hemor-
rhage.32 We think that this period of aggressive treatment 
Table 1.  Demographic and Baseline Data (N = 45 
Patients)
Variable Value
Age (y, median) 67 (43–79)
Male (%) 73
LOS-ICU (d, median) 7 (4–11)
MV-days (d, median) 6 (3–9)
First GCS (median) 6 (3–9)
First GCSm (median) 3 (1–5)
ISS (mean) 28 ± 12
AIS head (median) 4 (3–4)
SAPS II (mean) 54 ± 13
IMPACT mortality (%, mean) 51 ± 18
IMPACT unfavorable outcome 
(%, median)
76 (62–85)
Data are expressed as mean ± SD, median and IQR, or frequency (%) as 
appropriate.
Abbreviations: AIS head, Abbreviated Injury Scale score referring to the head 
region; GCS, Glasgow Coma Scale; GCSm, motor component of the GCS; 
IMPACT mortality, probability of mortality 6 mo after traumatic brain injury 
based on IMPACT prognostic model; IMPACT unfavorable outcome, probability 
of unfavorable outcome 6 mo after traumatic brain injury based on IMPACT 
prognostic model; ISS, Injury Severity Score; LOS-ICU, length of stay in the 
intensive care unit; MV-days, number of days on mechanical ventilation; SAPS 
II, Simplified Acute Physiologic Score II during the first 24 h at the intensive 
care unit.
Table 2.  Decision-Making Process Data (N = 43 
Patients)
Data Mean % (95% CI)
 Trigger for the end-of-life discussion  
  Doctors 85.7 (72.2%–93.3%)
  Family 14.3 (6.7%–27.8%)
 People involved in the end-of-life discussion  
  Doctors 100.0 (91.8%–100.0%)
  Nurses 78.9 (637%–88.9%)
  Relatives 97.7 (87.9%–99.9%)
  Ethics experts 2.3 (0.1%–12.1%)
  Legal guardians 2.3 (0.1%–12.3%)
 Surrogate decision maker  
  Relatives 97.7 (87.9%–99.9%)
  Ethics experts 2.3 (0.1%–12.1%)
 Presence of written advance directives 14.0 (6.6%–27.3%)
 End-of-life issues discussed with relatives 
before traumatic brain injury
34.9 (22.4%–49.8%)
Abbreviation: CI, confidence interval.
Table 3.  Data About End-of-Life Decision (N = 43 
Patients)
Data
Mean %  
(95% CI)
Median  
Days 
(IQR)
Withdrawal of life-prolonging 
therapies
83.7 (70.0%–91.9%)  
Withholding of life-prolonging 
therapies
46.5 (32.5%–61.1%)  
Alleviation of symptoms with 
sedatives/opiates
97.7 (87.9%–99.9%)  
Time from traumatic brain injury 
to end-of-life decision
 7 (4–14) 
Time from traumatic brain injury 
to death
 9 (6–15) 
Time from end-of-life  
decision to death
 1 (0–3) 
Abbreviations: CI, confidence interval; IQR, interquartile range.
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before redirection of care permits adequate observation of 
the evolution of the damage to better define prognosis.
In 85.7% (72.2%–93.3%) of cases, physicians triggered 
the decision to limit life-prolonging therapies. There is 
room for discussion about whether this slightly paternal-
istic approach is justified; however, physicians could lead 
well-considered discussions based on the prognosis and 
the patient’s values, as depicted by the SDM, or on his or 
her will as expressed in the AD. Relatives, when available, 
always participated in the EOL decision for their loved one. 
The content of these discussions was always reported in the 
medical records, in contrast to a previous study,33 which 
highlighted scarce documentation of these discussions.
ADs: Medical Representative
The Swiss law relating to the protection of adults is based on 
the patient’s autonomy: individuals have the right to make 
decisions based on their personal values and/or concepts. 
Written ADs, if available, are legally binding on the physician.
In our population, ADs (14.0%, 95% CI, 6.6%–27.3%) and 
discussions about EOL issues with relatives before trauma 
(34.9%, 95% CI, 22.4%–49.8%) were rare, as was also found 
in a recent paper performed in a Norwegian center.31 This 
is probably due to the sudden nature of TBI34 and the rela-
tive young age of the study population. Older patients 
with chronic illnesses are more likely to face the topic.35,36 
Nevertheless, the prevalence of ADs in Swiss terminal 
cancer patients remains low (29%),37 revealing the lack of 
advance care planning concepts in Switzerland. This is dif-
ferent from other countries,38,39 where discussions about 
advance care planning are part of routine health care.
In most cases, patients did not give any instruction, and a 
SDM granted consent to medical interventions based on the 
patient’s presumed will. Because TBI often occurs suddenly 
and without warning, we recommend that even young peo-
ple develop ADs and share them with their families; start-
ing advance care planning early may help to alleviate some 
of the stress felt by relatives who are burdened by making 
EOL decisions.40
However, limitations of advance care planning must be 
considered. The drawing up of ADs requires engagement 
with death. In healthy phases of life, it is nearly possible 
to transpose oneself into the situation of a serious illness, 
and it is hard to imagine in advance which medical mea-
sures one would accept in extreme situations. Moreover, 
the degree of disability that patients can bear is higher than 
what they expected before the injury (disability paradox).23
Limitations
Our conclusions are limited by the study’s retrospective 
nature and by the fact that it is a single-center study and 
consequently not representative of the country as a whole. 
Moreover, we collected data only on patients with TBI (GOS 1) 
who died within 6 months of their injury and, therefore, do 
not know if EOL decisions were taken even for patients who 
survived.
CONCLUSIONS
At our ICU, EOL decisions in patients with moderate or 
severe TBI are made frequently after interdisciplinary 
prognostication and involvement of the SDM. A possible 
consequence of this high rate of conscious EOL decisions fol-
lowed by limitation of life-prolonging therapies is a negligible 
rate of patients in vegetative state compared to findings from 
previous studies. EOL decision making is challenging for 
both SDMs and health care professionals. Due to the sudden 
nature of TBI, we recommend that even young people write 
down ADs: starting advance care planning early could allevi-
ate the stress felt by relatives burdened by decision making. 
Furthermore, we recommend a shared decision-making pro-
cess: even if physicians initiate the discussion, representatives 
must be involved and the patient’s will must be considered.
It would be interesting to conduct a multicenter study 
in different countries to analyze the differences in EOL pro-
cesses in TBI patients and if/how these differences affect the 
outcome of this vulnerable group of patients. E
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